Blood test may predict cancer treatment success

NCT ID NCT04056247

Ongoing Knowledge-focused Sponsor: OncoHost Ltd. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study aims to create a tool that can predict whether a cancer patient will benefit from their prescribed therapy. Researchers are analyzing blood samples from 10,000 people with advanced lung cancer or melanoma before and during treatment. The goal is to develop an algorithm that helps doctors choose the most effective treatment for each patient.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for STAGE III UNRESECTABLE NON-SMALL CELL LUNG CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cutaneous melanoma melanoma metastatic melanoma non-small cell lung carcinoma small cell lung carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

STAGE III UNRESECTABLE NON-SMALL CELL LUNG CANCER STAGE IIIB-D MALIGNANT MELANOMA STAGE IV MALIGNANT MELANOMA STAGE IV NON-SMALL CELL LUNG CANCER STAGE IV SMALL CELL LUNG CANCER

Contacts and locations

Locations

044 Hospital Universitario Virgen Macarena

Seville, Spain
151-Christus Health St. Michael

Texarkana, Texas, 75503, United States
Aberdeen Royal Infirmary

Aberdeen, United Kingdom
Asklepois

Gauting, 82131, Germany
Assuta Medical Cetner

Tel Aviv, Israel
Barzilai Medical Center

Ashkelon, Israel
Birmingham VAHCS

Birmingham, Alabama, 35233, United States
Bnai Zion Medical Center

Haifa, Israel
Bradford Teaching Hospitals

Bradford, BD9 6RJ, United Kingdom
Cheltenham General Hospital

Cheltenham, United Kingdom
Florida Cancer Specialist and Research Institute

Orlando, Florida, 32827, United States
Hadassah Medcial Center

Jerusalem, Israel
Haemek Medical Center

Afula, Israel
Helen Nassif Community Cancer Center

Cedar Rapids, Iowa, 52403, United States
Kaplan Medical Center

Rehovot, Israel
Lister Hospital

Stevenage, United Kingdom
Mayo Clinic

Jacksonville, Florida, 32224, United States
Meir medical center

Kfar Saba, Israel
Michael E. Debakey VA Medical Center

Houston, Texas, 77030, United States
Mount Vernon Cancer Centre

Northwood, United Kingdom
Northwest Community Healthcare

Rolling Meadows, Illinois, 60008, United States
Protean Biodiagnosics

Orlando, Florida, 32827, United States
Rabin Medical Center

Petah Tikva, Israel
Rambam Medical Center

Haifa, Israel
Roswell Park

Buffalo, New York, 14263, United States
Royal Bournemouth General Hospital

Bournemouth, United Kingdom
Rutgers Cancer Institute

New Brunswick, New Jersey, 08903, United States
Shamir Medical Center

Be’er Ya‘aqov, Israel
Sheba Medical Center

Tel Aviv, Israel
Sheba medical center

Tel Litwinsky, Israel
Soroka Medical Center

Beersheba, Israel
Sourasky Medical Center

Tel Aviv, Israel
South Tyneside

South Shields, NE34 0PL, United Kingdom
Sunderland Royal Hospital

Sunderland, SR4 7TP, United Kingdom
Swansea Bay UHB Singleton Hospital

Swansea, United Kingdom
The Shrewsbury and Telford Hospital

Shrewsbury, United Kingdom
Thoraxklinik Heidelberg gGmbH

Heidelberg, 69126, Germany
Torbay Hospital

Torquay, United Kingdom
University of Miami

Miami, Florida, 33136, United States
West Clinic

Germantown, Tennessee, 38138, United States
Withybush Hospital

Haverfordwest, SA61 2PZ, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.